These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7306443)

  • 1. Radioreceptor assay for labetalol.
    Kelly JG; McGarry K; O'Malley K
    Br J Clin Pharmacol; 1981 Aug; 12(2):258-60. PubMed ID: 7306443
    [No Abstract]   [Full Text] [Related]  

  • 2. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection.
    Meredith PA; McSharry D; Elliott HL; Reid JL
    J Pharmacol Methods; 1981 Dec; 6(4):309-14. PubMed ID: 7334812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of labetalol in human plasma by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Jul; 175(1):208-10. PubMed ID: 546907
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.
    Hidalgo IJ; Muir KT
    J Chromatogr; 1984 Jan; 305(1):222-7. PubMed ID: 6707148
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection.
    Oosterhuis B; van den Berg M; van Boxtel CJ
    J Chromatogr; 1981 Nov; 226(1):259-65. PubMed ID: 7320152
    [No Abstract]   [Full Text] [Related]  

  • 6. Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.
    Sanders GL; Routledge PA; Ward A; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):153S-155S. PubMed ID: 526396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pressure liquid chromatography on labetalol in serum or plasma.
    Woodman TF; Johnson B
    Ther Drug Monit; 1981; 3(4):371-5. PubMed ID: 7336471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol steady-state pharmacokinetics in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ; Raymond K
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):75S-80S. PubMed ID: 7093102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of onset of hypotensive response with oral labetalol [proceedings].
    Breckenridge AM; Macnee CM; Orme NL; Richards DA; Sterlin MJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):388P. PubMed ID: 901712
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol in essential hypertension.
    Breckenridge A; Orme M; Serlin MJ; Maciver M
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the labetalol-induced changes in conductivity and refractoriness of the dog heart in situ.
    Amlie JP
    Cardiovasc Res; 1978 Nov; 12(11):646-52. PubMed ID: 750077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 15. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine brain radioreceptor assay for non-specific opioid peptide screening in dog heart extracts.
    Barron BA; Caffrey JL
    Prog Clin Biol Res; 1990; 328():93-6. PubMed ID: 2154827
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J; Pakkanen A; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):191-4. PubMed ID: 7390669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of intravenous labetalol on hemodynamics and myocardial metabolism in coronary insufficiency].
    Lardoux H; Ourbak P; Pornin M; Duong TC; Chouty F; Maurice P
    Therapie; 1983; 38(2):149-54. PubMed ID: 6636022
    [No Abstract]   [Full Text] [Related]  

  • 20. Labetalol disposition and concentration-effect relationships during pregnancy.
    Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
    Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.